BetaGlue Technologies is a clinical-stage precision oncology company developing localized radiotherapeutic platforms for solid tumors, particularly focusing on pancreatic cancer
BetaGlue Technologies is a clinical-stage precision oncology company developing localized radiotherapeutic platforms for solid tumors, particularly focusing on pancreatic cancer. Their flagship product, YntraDose, is a first-in-class localized radiotherapeutic platform that delivers radiation directly to tumors.